10x Genomics (TXG) Leases (2020 - 2026)

10x Genomics' Leases history runs 7 years deep, the most recent figure standing at $58.4 million for Q1 2026.

• In Q1 2026, Leases rose 5.06% year-over-year to $58.4 million; the TTM figure through Mar 2026 stood at $58.4 million (up 5.06% YoY), while the FY2025 annual figure was $60.4 million, up 5.52% from the prior year.
• Leases came in at $58.4 million for Q1 2026 at 10x Genomics, down from $60.4 million in the prior quarter.
• In the past five years, Leases ranged from a high of $75.7 million in Q1 2022 to a low of $55.6 million in Q1 2025.
• A 5-year average of $65.4 million and a median of $63.6 million in 2025 frame the typical range for Leases.
• Across the five-year window, Leases surged 35.66% in 2022 and decreased 15.91% in 2024, its largest moves.
• 10x Genomics' Leases stood at $69.9 million in 2022, then decreased by 6.47% to $65.4 million in 2023, then slipped by 12.35% to $57.3 million in 2024, then increased by 5.52% to $60.4 million in 2025, then fell by 3.41% to $58.4 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $58.4 million, $60.4 million, and $63.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison